摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-2',4'-dimethoxyflavone | 1119807-90-7

中文名称
——
中文别名
——
英文名称
6-bromo-2',4'-dimethoxyflavone
英文别名
Flavonid, 6d;6-bromo-2-(2,4-dimethoxyphenyl)chromen-4-one
6-bromo-2',4'-dimethoxyflavone化学式
CAS
1119807-90-7
化学式
C17H13BrO4
mdl
——
分子量
361.192
InChiKey
DJOKTCJODXHCDU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of biflavones having a 6-O-7’’ linkage and effects on cyclooxygenase-2 and inducible nitric oxide synthase
    摘要:
    In order to establish anti-inflammatory potential of biflavonoids, 17 biflavone derivatives having a 6-O-7 '' linkage were synthesized and their effects on cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) were evaluated. The basic molecule (6-O-7 '' biflavone) potently inhibited COX-2-mediated PGE(2) production (IC50: < 2 mu M), being less active on iNOS-mediated NO production (IC50: > 50 mu M) from lipopolysaccharide-treated RAW 264.7 cells, a mouse macrophage cell line. Generally, the hydroxyl/methoxyl substitution(s) on the basic biflavone (6-O-7 '') reduced the inhibitory activity of PGE(2) production, while the effects on NO production were varied. It is suggested that the basic biflavone (6-O-7 '') may have a potential for new anti-inflammatory agent. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.11.017
  • 作为产物:
    描述:
    5'-bromo-2'-hydroxy-2,4-dimethoxychalcone 作用下, 以 二甲基亚砜 为溶剂, 反应 0.33h, 以75%的产率得到6-bromo-2',4'-dimethoxyflavone
    参考文献:
    名称:
    作为有效的组织蛋白酶V抑制剂的Chalcones和Flavones组合文库的溶液相合成
    摘要:
    组织蛋白酶V是一种木瓜蛋白酶样半胱氨酸蛋白酶。它参与人类T细胞的控制(负责细胞免疫),并在蛋白水解酶中表现出最大的弹性。因此,组织蛋白酶V是治疗动脉粥样硬化的潜在分子靶标。在目前的工作中,针对组织蛋白酶V筛选了天然类黄酮,并确定了两种黄酮是组织蛋白酶V的有效抑制剂。基于此结果,在溶液相中使用清道夫试剂制备了查尔酮和黄酮的组合文库,并经过充分评估。
    DOI:
    10.1021/cc100076k
点击查看最新优质反应信息

文献信息

  • Solution Phase Synthesis of a Combinatorial Library of Chalcones and Flavones as Potent Cathepsin V Inhibitors
    作者:Joel Alvim、Richele P. Severino、Emerson F. Marques、Ariane M. Martinelli、Paulo C. Vieira、João B. Fernandes、M. Fatima das G. F. da Silva、Arlene G. Corrêa
    DOI:10.1021/cc100076k
    日期:2010.9.13
    Cathepsin V is a papain-like cysteine protease. It is involved in the control of human T cells (responsible for cell immunity), and presents the largest elastolytic activity among the proteolytic enzymes. Therefore, cathepsin V is a potential molecular target for the treatment of atherosclerosis. In the present work, natural flavonoids were screened against cathepsin V, and two flavones were identified
    组织蛋白酶V是一种木瓜蛋白酶样半胱氨酸蛋白酶。它参与人类T细胞的控制(负责细胞免疫),并在蛋白水解酶中表现出最大的弹性。因此,组织蛋白酶V是治疗动脉粥样硬化的潜在分子靶标。在目前的工作中,针对组织蛋白酶V筛选了天然类黄酮,并确定了两种黄酮是组织蛋白酶V的有效抑制剂。基于此结果,在溶液相中使用清道夫试剂制备了查尔酮和黄酮的组合文库,并经过充分评估。
  • Synthesis of biflavones having a 6-O-7’’ linkage and effects on cyclooxygenase-2 and inducible nitric oxide synthase
    作者:Haiyan Che、Byung Kyu Park、Hyun Lim、Hyun Pyo Kim、Hyeun Wook Chang、Jin-Hyun Jeong、Haeil Park
    DOI:10.1016/j.bmcl.2008.11.017
    日期:2009.1
    In order to establish anti-inflammatory potential of biflavonoids, 17 biflavone derivatives having a 6-O-7 '' linkage were synthesized and their effects on cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) were evaluated. The basic molecule (6-O-7 '' biflavone) potently inhibited COX-2-mediated PGE(2) production (IC50: < 2 mu M), being less active on iNOS-mediated NO production (IC50: > 50 mu M) from lipopolysaccharide-treated RAW 264.7 cells, a mouse macrophage cell line. Generally, the hydroxyl/methoxyl substitution(s) on the basic biflavone (6-O-7 '') reduced the inhibitory activity of PGE(2) production, while the effects on NO production were varied. It is suggested that the basic biflavone (6-O-7 '') may have a potential for new anti-inflammatory agent. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多